← Back to Search

High vs Low Intensity Treatment Strategies for Opioid Addiction (EXHITENTRE Trial)

N/A
Recruiting
Research Sponsored by Hennepin Healthcare Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Provide inpatient general medical care
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 34 days following hospital discharge
Awards & highlights

EXHITENTRE Trial Summary

This trial is testing two different strategies for implementing medication-based treatment for opioid addiction in community hospitals.

Who is the study for?
This trial is for community hospitals that want to start treating opioid use disorder (OUD) in hospitalized patients. Hospitals must be willing to adopt new treatment strategies, have staff trained, and work with a site champion. They should not already have an opioid treatment program or be a Veterans Affairs hospital.Check my eligibility
What is being tested?
The study compares two methods of implementing hospital-based opioid use disorder treatments: one with low-intensity support and another with high-intensity support. It aims to see which strategy better supports the adoption of medication treatments for OUD in community hospitals.See study design
What are the potential side effects?
Since this trial focuses on implementation strategies rather than direct patient interventions, it does not directly involve side effects related to medications or treatments.

EXHITENTRE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am receiving general medical care as a hospital inpatient.

EXHITENTRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~34 days following hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 34 days following hospital discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Engagement with MOUD

EXHITENTRE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High IntensityExperimental Treatment1 Intervention
MOUD training and support through the use of educational materials in addition to practice facilitation.
Group II: Low IntensityActive Control1 Intervention
MOUD training and support through the use of educational materials.

Find a Location

Who is running the clinical trial?

Hennepin Healthcare Research InstituteLead Sponsor
90 Previous Clinical Trials
77,153 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,455 Previous Clinical Trials
2,596,940 Total Patients Enrolled
The Emmes Company, LLCIndustry Sponsor
145 Previous Clinical Trials
1,051,467 Total Patients Enrolled

Media Library

High Intensity Clinical Trial Eligibility Overview. Trial Name: NCT04921787 — N/A
Substance Use Disorder Research Study Groups: Low Intensity, High Intensity
Substance Use Disorder Clinical Trial 2023: High Intensity Highlights & Side Effects. Trial Name: NCT04921787 — N/A
High Intensity 2023 Treatment Timeline for Medical Study. Trial Name: NCT04921787 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity for participants to join this research project?

"Affirmative. According to the clinicaltrials.gov website, this medical research project is still actively seeking participants and was first posted on October 22nd 2021 before being updated most recently on March 30th 2022. The study requires 24 individuals at 4 different locations in order to be successful."

Answered by AI

How many individuals have enrolled in this clinical study thus far?

"Affirmative. According to clinicaltrials.gov, the trial is still actively recruiting patients since its initial posting on October 22nd 2021 and last update on March 30th 2022. 24 participants are required from 4 distinct medical centres."

Answered by AI

Are there a multitude of locations administering this medical experiment in the city?

"Oregon Health & Science University, Hennepin Healthcare Research Institute, and New york University are amongst the many sites that will be accepting patients for this trial."

Answered by AI

Who else is applying?

What state do they live in?
California
Tennessee
How old are they?
18 - 65
What site did they apply to?
Oregon Health & Science University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
~10 spots leftby Dec 2025